Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA05 TACROLIMUSUM CAPS. ELIB. PREL 0,5 mg

ADVAGRAF 0,5 mg 0,5 mg ASTELLAS PHARMA GMBH
L04AA05 TACROLIMUSUM CAPS. 0.5 mg

PROGRAF(R) 0,5 mg 0.5 mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM CAPS. 1 mg

PROGRAF(R) 1 mg 1 mg ASTELLAS IRELAND CO. LTD.

L04AA05 TACROLIMUSUM CAPS. ELIB. PREL. 1 mg

ADVAGRAF 1 mg 1 mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM CAPS. 5 mg

PROGRAF(R) 5 mg 5 mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM CAPS. ELIB. PREL. 5 mg

ADVAGRAF 5 mg 5 mg ASTELLAS PHARMA GMBH

L04AA05 TACROLIMUSUM CONC. PT. SOL. PERF. 5 mg/ml

PROGRAF(R) 5 mg/ml 5 mg/ml ASTELLAS PHARMA GMBH

________________________________________________________________________________
______________________________________________________________________________

| 914 |L04AA06| MYCOPHENOLATUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 180 mg

MYFORTIC 180 mg 180 mg NOVARTIS PHARMA GMBH
L04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALA 1 g/5 ml

CELLCEPT 1 mg/5 ml 1 g/5 ml ROCHE REGISTRATION LTD.

L04AA06 MYCOPHENOLATUM CAPS. 250 mg

CELLCEPT 250 mg 250 mg ROCHE REGISTRATION LTD.

MYFENAX 250 mg 250 mg TEVA PHARMA BV
L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 360 mg

MYFORTIC 360 mg 360 mg NOVARTIS PHARMA GMBH

L04AA06 MYCOPHENOLATUM CAPS. 500 mg

MYFENAX 500 mg 500 mg TEVA PHARMA BV

L04AA06 MYCOPHENOLATUM COMPR. FILM. 500 mg

CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD.

L04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. 500 mg

SOL. PERF.

CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD.

________________________________________________________________________________

______________________________________________________________________________

| 915 |L04AA08| DACLIZUMABUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA08 DACLIZUMABUM CONC. PT. SOL. PERF. 5 mg/ml

ZENAPAX 5 mg/ml 5 mg/ml ROCHE REGISTRATION LTD.

________________________________________________________________________________

______________________________________________________________________________

| 916 |L04AA10| SIROLIMUS** | |

|_______|_______|____________________________________________|_________________|
Monitorizarea atentă a pacienţilor este obligatorie